Your browser doesn't support javascript.
loading
Optimizing the Design and Analysis of Future AKI Trials.
Legrand, Matthieu; Bagshaw, Sean M; Koyner, Jay L; Schulman, Ivonne H; Mathis, Michael R; Bernholz, Juliane; Coca, Steven; Gallagher, Martin; Gaudry, Stéphane; Liu, Kathleen D; Mehta, Ravindra L; Pirracchio, Romain; Ryan, Abigail; Steubl, Dominik; Stockbridge, Norman; Erlandsson, Fredrik; Turan, Alparslan; Wilson, F Perry; Zarbock, Alexander; Bokoch, Michael P; Casey, Jonathan D; Rossignol, Patrick; Harhay, Michael O.
Affiliation
  • Legrand M; Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California San Francisco, San Francisco, California.
  • Bagshaw SM; French Clinical Research Infrastructure Network, Investigation Network Initiative Cardiovascular and Renal Trialists, Nancy, France.
  • Koyner JL; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
  • Schulman IH; Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Mathis MR; Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
  • Bernholz J; Department of Anesthesiology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan.
  • Coca S; AM-Pharma, Utrecht, The Netherlands.
  • Gallagher M; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Gaudry S; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Liu KD; French Clinical Research Infrastructure Network, Investigation Network Initiative Cardiovascular and Renal Trialists, Nancy, France.
  • Mehta RL; Département de Réanimation, Medical and surgical intensive care unit, Assistance Publique-Hôpitaux de Paris Hôpital Avicenne, Bobigny, France.
  • Pirracchio R; Common and Rare Kidney Diseases, Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1155, Paris, France.
  • Ryan A; Divisions of Nephrology and Critical Care Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, California.
  • Steubl D; Department of Medicine, University of California San Diego, San Diego, California.
  • Stockbridge N; Department of Anesthesia and Perioperative Medicine, University of California San Francisco, San Francisco, California.
  • Erlandsson F; Division of Chronic Care Management, Chronic Care Policy Group, Center for Medicare, Center for Medicare and Medicaid Services, Baltimore, Maryland.
  • Turan A; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Wilson FP; Department of Nephrology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
  • Zarbock A; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
  • Bokoch MP; Vifor Pharma AG, Zurich, Switzerland.
  • Casey JD; Department of Anesthesiology, Lerner College of Medicine of Case Western University, Cleveland, Ohio.
  • Rossignol P; Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.
  • Harhay MO; Section of Nephrology and Clinical and Translational Research Accelerator, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
J Am Soc Nephrol ; 33(8): 1459-1470, 2022 08.
Article in En | MEDLINE | ID: mdl-35831022

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Critical Illness Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2022 Type: Article